Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

• Status: Completed
• Trial end date: 2001-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

To compare the therapeutic and radiographic effects and safety between etanercept, methotrexate, and the etanercept/methotrexate combination in patients with rheumatoid arthritis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Etanercept; Methotrexate

Criteria

Inclusion:

• Generally healthy of at least 18 years of age with active rheumatoid arthritis.

Exclusion:

• A history or presence of clinically important medical disease.